health ๐ Pfizer stresses patient safety amid fake drug probe
Pfizer stated that patient safety and product quality remain its highest priorities following the probe into counterfeit drugs. The Karnataka FDA took action on Sunday, cancelling 16 drug licenses and suspending eight others. This followed an August 18 inspection where spurious drugs and machinery worth Rs 5.05 crore were seized in Bengaluru. The scam allegedly involved repacking cheap medicines as expensive life-saving drugs, including those bearing the Pfizer brand. Pfizer continues to cooperate with authorities to resolve open queries and protect public health. ๐